Sun Pharma has been stung by a decade-old pay-for-delay lawsuit, one of a of a host of issues that contributed to a 74% profit slide.
Perrigo surprised its investors Thursday with better than expected results and announced it was selling its API business for $110 million.
Most pharmaceutical companies work with an average of seven bioanalytical labs in a given year, taking time and scientists away from important research and…
German regulators have pulled the manufacturing certificate for Dr. Reddy’s formulation plant in India.
A two-year-old CDMO that has created its manufacturing network snapping up unwanted plants is buying a former Hospira sterile plant from Pfizer. …
A global shortage of hepatitis B vaccine has developed as both Merck & Co. and GlaxoSmithKline deal with manufacturing issues.
Pfizer committed to building a $100 million gene therapies plant in North Carolina. The project is expected to create 40 jobs.
A Canadian company that sells topical vitamin C skin treatments is in trouble with the FDA, which says it needs is a dose of cGMP practices.
The FDA has again turned down approval of a new eye drug from Valeant because of manufacturing issues at its Bausch + Lomb plant in Tampa, Florida.
The Biocon sterile manufacturing plant that got spanked by European and FDA regulators earlier this year has taken another whipping by the FDA.
Shire has found a buyer for a former Baxter vaccine plant in Europe as it continues its manufacturing consolidation after buying Baxalta.